IQVIA Europe and Africa — Revenue decreased by 4.8% to $1.36B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.7%, from $1.22B to $1.36B. Over 4 years (FY 2021 to FY 2025), Europe and Africa — Revenue shows an upward trend with a 4.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates successful regional sales growth, market penetration, or higher demand for clinical trial services, while a decrease may signal regional economic headwinds or loss of competitive positioning.
This metric represents the total gross revenue generated from clinical research, technology, and healthcare analytics se...
Comparable to regional revenue reporting for global CROs and healthcare data providers, often benchmarked against regional GDP growth and pharmaceutical R&D spending trends.
iqv_segment_europe_and_africa_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.11B | $1.02B | $1.14B | $1.15B | $1.12B | $1.03B | $1.07B | $1.09B | $1.12B | $1.09B | $1.16B | $1.16B | $1.18B | $1.29B | $1.30B | $1.22B | $1.24B | $1.30B | $1.42B | $1.36B |
| QoQ Change | — | -8.5% | +12.1% | +0.6% | -3.0% | -7.5% | +3.9% | +2.1% | +2.0% | -2.4% | +6.5% | -0.3% | +1.8% | +9.3% | +0.9% | -5.7% | +1.4% | +4.5% | +9.7% | -4.8% |
| YoY Change | — | — | — | — | +0.1% | +1.2% | -6.2% | -4.8% | +0.1% | +5.6% | +8.3% | +5.8% | +5.6% | +18.2% | +11.9% | +5.8% | +5.3% | +0.8% | +9.6% | +10.7% |